GCG

Gene Information
 
Gene Symbol
GCG
 
Aliases
GLP-1, GLP1, GLP2, GRPP
 
Entrez Gene ID
 
Gene Name
Glucagon
 
Chromosomal Location
2q24.2
 
HGNC ID
 
Summary
The protein encoded by this gene is actually a preproprotein that is cleaved into four distinct mature peptides. One of these, glucagon, is a pancreatic hormone that counteracts the glucose-lowering action of insulin by stimulating glycogenolysis and gluconeogenesis. Glucagon is a ligand for a specific G-protein linked receptor whose signalling pathway controls cell proliferation. Two of the other peptides are secreted from gut endocrine cells and promote nutrient absorption through distinct mechanisms. Finally, the fourth peptide is similar to glicentin, an active enteroglucagon. [provided by RefSeq, Jul 2008]
  e!Ensembl
Gene
Transcript  
Protein

Gene Ontology (GO)

GO ID Ontology Function Evidence Reference
GO:0007186 Biological process G protein-coupled receptor signaling pathway TAS 7929237
GO:0007188 Biological process Adenylate cyclase-modulating G protein-coupled receptor signaling pathway IBA 21873635
GO:0007631 Biological process Feeding behavior TAS 8538742
GO:0010737 Biological process Protein kinase A signaling IBA 21873635
GO:0035774 Biological process Positive regulation of insulin secretion involved in cellular response to glucose stimulus IBA 21873635
Protein Information
 
Protein Name
Glucagon, glicentin-related polypeptide, glucagon-like peptide 1, glucagon-like peptide 2, preproglucagon
 
Function
Glucagon plays a key role in glucose metabolism and homeostasis. Regulates blood glucose by increasing gluconeogenesis and decreasing glycolysis. A counterregulatory hormone of insulin, raises plasma glucose levels in response to insulin-induced hypoglycemia. Plays an important role in initiating and maintaining hyperglycemic conditions in diabetes.; GLP-1 is a potent stimulator of glucose-dependent insulin release. Play important roles on gastric motility and the suppression of plasma glucagon levels. May be involved in the suppression of satiety and stimulation of glucose disposal in peripheral tissues, independent of the actions of insulin. Have growth-promoting activities on intestinal epithelium. May also regulate the hypothalamic pituitary axis (HPA) via effects on LH, TSH, CRH, oxytocin, and vasopressin secretion. Increases islet mass through stimulation of islet neogenesis and pancreatic beta cell proliferation. Inhibits beta cell apoptosis.; GLP-2 stimulates intestinal growth and up-regulates villus height in the small intestine, concomitant with increased crypt cell proliferation and decreased enterocyte apoptosis. The gastrointestinal tract, from the stomach to the colon is the principal target for GLP-2 action. Plays a key role in nutrient homeostasis, enhancing nutrient assimilation through enhanced gastrointestinal function, as well as increasing nutrient disposal. Stimulates intestinal glucose transport and decreases mucosal permeability.; Oxyntomodulin significantly reduces food intake. Inhibits gastric emptying in humans. Suppression of gastric emptying may lead to increased gastric distension, which may contribute to satiety by causing a sensation of fullness.; Glicentin may modulate gastric acid secretion and the gastro-pyloro-duodenal activity. May play an important role in intestinal mucosal growth in the early period of life
 
UniProt
 
PDB
 
Pfam
Pfam Accession Pfam ID
PF00123 Hormone_2
Pathways
 
KEGG
 
Reactome
 

cAMP signaling pathway
Neuroactive ligand-receptor interaction
Thermogenesis
Insulin secretion
Glucagon signaling pathway

 

Glucagon signaling in metabolic regulation
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)
G alpha (q) signalling events
G alpha (s) signalling events
Glucagon-type ligand receptors
Synthesis, secretion, and deacylation of Ghrelin
ADORA2B mediated anti-inflammatory cytokines production

Interactions
 
STRING MINT IntAct
ENSP00000221421 P01229
    View interactions
     

Associated Diseases

Disease groupDisease NameReferences
Cardiovascular Diseases
Heart Diseases
Vascular Diseases
Heart Failure
Myocardial Failure
Sinus Tachycardia
References
 
 
PubMed ID Associated gene/s Associated condition Genetic Mutation Diagnostic Criteria Association with PCOS Ethnicity Conclusion
GIP 
Type 2 diabetes mellitus 
 
 
Related 
 
 

| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412